# Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

> **NCT00202540** · PHASE2 · TERMINATED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 38 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** S18986

## Key facts

- **NCT ID:** NCT00202540
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2006-03-29
- **Final completion:** 2006-03-29
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202540, "Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00202540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*